Solution Spotlight with Nanoform Nanoparticle Production with Supercritical CO2

11:55 - 12:30

  • We produce Pure Homogenous Nanoparticles under 20 nm
  • Improving bioavailability
  • Nanonization services aimed at present for pre-clinical investigations
  • Gearing up for process optimization, clinical trials and GMP manufacturing

Professor Edward Hæggström, Chief Executive Officer, Nanoform